Linked Life Data

16969329

Source:http://linkedlifedata.com/resource/pubmed/id/16969329

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9 Pt 2
pubmed:dateCreated
2006-9-13
pubmed:abstractText
Positron emission tomography (PET), like scintigraphy, is a type of functional and molecular imaging. Image resolution is better than with scintigraphy, and tomographic slices are obtained, as with CT and MRI. Modern PET machines are coupled with CT (PET/CT) and yield fused images that combine metabolic and anatomic approaches. Fludeoxyglucose (FDG), a radiolabeled glucose analog, is the most widely used radiopharmaceutical for clinical PET, but several other molecules are proposed for routine use. Clinical trials will determine which are of clinical interest. FDG imaging necessarily involves PET but clinical PET is not only FDG imaging.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0755-4982
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1331-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Basics of PET and PET/CT imaging: instrumentation and radiopharmaceuticals for clinical diagnosis].
pubmed:affiliation
Service de Médecine Nucléaire et Centre TEP, AP-HP Hôpital Tenon et Université Pierre et Marie Curie, Paris. jean-noel.talbot@tnn.ap-hop-paris.fr
pubmed:publicationType
Journal Article, English Abstract, Review